Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MACROGENICS INCMGNX · Entity 6104 | Sr VP, Research & CSO | October 06, 2026 | October 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MACROGENICS INC
Report date October 06, 2026 · Filed October 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 193,799 |
Reported balance
After 2026-10-06 transaction · row 1
1 source rowRow 1 · 2026-10-06 · Exercise / conversion · Acquired 8,000 · Balance 193,799 F1: The transaction represents an exercise and hold of options. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.60 · Expires 2035-02-07 | Direct | 80,000 |
Reported balance
After 2026-10-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-06 · Exercise / conversion · Disposed 8,000 · Balance 80,000 F2: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction represents an exercise and hold of options.
F2: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 06, 2026 Filed Oct 7, 2026 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,000 | $2.60 Strike: $2.60 | $20,800.00 |
DisclosureSEC source: 0001125345-26-000063 · wk-form4_1791404574.xml · derivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 8,000 shares Expires 2035-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
| October 06, 2026 Filed Oct 7, 2026 20:22 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 8,000 | $2.60 | $20,800.00 |
DisclosureSEC source: 0001125345-26-000063 · wk-form4_1791404574.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction represents an exercise and hold of options. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 20:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 40,000 | $2.60 Strike: $2.60 | $104,000.00 |
DisclosureSEC source: 0001588365-26-000007 · wk-form4_1787084342.xml · derivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,000 Underlying: Common Stock · 40,000 shares Expires 2035-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
| August 17, 2026 Filed Aug 18, 2026 20:19 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 40,000 | $2.60 | $104,000.00 |
DisclosureSEC source: 0001588365-26-000007 · wk-form4_1787084342.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction represents an exercise and hold of options. Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 23:27 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 16,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001588365-26-000005 · wk-form4_1771370829.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 23:27 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 6,433 | $1.71 | $11,000.43 |
DisclosureSEC source: 0001588365-26-000005 · wk-form4_1771370829.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,799 Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 23:27 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 16,665 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001588365-26-000005 · wk-form4_1771370829.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 15, 2023, the reporting person was granted 50,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 23:27 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 187,500 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001588365-26-000005 · wk-form4_1771370829.xml · derivative · entry 5 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,500 Underlying: Common Stock · 187,500 shares Expires 2036-02-12 F3 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 23:27 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 31,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001588365-26-000005 · wk-form4_1771370829.xml · derivative · entry 4 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 31,250 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F2 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F2 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 23:13 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 11,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001588365-26-000002 · wk-form4_1770765218.xml · derivative · entry 6 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,166 Underlying: Common Stock · 11,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into the Company's stock on a one-for-one basis. F3 · derivative.exercise_date: On February 8, 2024, the reporting person was granted 33,500 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On February 8, 2024, the reporting person was granted 33,500 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 23:13 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 4,311 | $1.81 | $7,802.91 |
DisclosureSEC source: 0001588365-26-000002 · wk-form4_1770765218.xml · nonDerivative · entry 4 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,567 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 23:13 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 11,166 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001588365-26-000002 · wk-form4_1770765218.xml · nonDerivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 23:13 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 7,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001588365-26-000002 · wk-form4_1770765218.xml · derivative · entry 5 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,999 Underlying: Common Stock · 7,001 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into the Company's stock on a one-for-one basis. F2 · derivative.exercise_date: On February 7, 2025, the reporting person was granted 21,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On February 7, 2025, the reporting person was granted 21,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 23:13 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 2,703 | $1.81 | $4,892.43 |
DisclosureSEC source: 0001588365-26-000002 · wk-form4_1770765218.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,712 Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 23:13 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 7,001 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001588365-26-000002 · wk-form4_1770765218.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:31 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 16,665 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-25-000037 · wk-form4_1740000666.xml · derivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,665 Underlying: Common Stock · 16,665 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:31 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 16,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-25-000037 · wk-form4_1740000666.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 08, 2025 Filed Feb 12, 2025 01:33 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 11,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-25-000019 · wk-form4_1739324028.xml · derivative · entry 5 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,332 Underlying: Common Stock · 11,168 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 08, 2025 Filed Feb 12, 2025 01:33 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 4,311 | $2.60 | $11,208.60 |
DisclosureSEC source: 0001125345-25-000019 · wk-form4_1739324028.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,749 Read SEC document |
| February 08, 2025 Filed Feb 12, 2025 01:33 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 11,168 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001125345-25-000019 · wk-form4_1739324028.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 01:33 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 21,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-25-000019 · wk-form4_1739324028.xml · derivative · entry 4 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 01:33 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 128,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001125345-25-000019 · wk-form4_1739324028.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,000 Underlying: Common Stock · 128,000 shares Expires 2035-02-07 F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:26 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 28,125 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-24-000046 · wk-form4_1708982768.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:26 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 9,366 | $17.11 | $160,252.26 |
DisclosureSEC source: 0001125345-24-000046 · wk-form4_1708982768.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,892 Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 21:26 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 28,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-24-000046 · wk-form4_1708982768.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% vested on February 22, 2024. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 23:03 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 16,670 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-24-000035 · wk-form4_1708470190.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,330 Underlying: Common Stock · 16,670 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 23:03 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 5,871 | $17.40 | $102,155.40 |
DisclosureSEC source: 0001125345-24-000035 · wk-form4_1708470190.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,133 Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 23:03 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 16,670 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-24-000035 · wk-form4_1708470190.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 15, 2023 the reporting person was granted 50,000 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:32 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 33,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-24-000022 · wk-form4_1707777143.xml · derivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,500 Underlying: Common Stock · 33,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 22:32 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $18.30 | $0.00 |
DisclosureSEC source: 0001125345-24-000022 · wk-form4_1707777143.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2034-02-08 F1 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
| February 07, 2024 Filed Feb 7, 2024 21:19 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 3,334 | $18.00 | $60,012.00 |
DisclosureSEC source: 0001125345-24-000008 · wk-form4_1707340726.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,334 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:21 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 13,316 | $15.00 | $199,740.00 |
DisclosureSEC source: 0001125345-24-000004 · wk-form4_1706908871.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,668 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023. Read SEC document |
| January 19, 2024 Filed Jan 22, 2024 21:57 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 13,316 | $12.00 | $159,792.00 |
DisclosureSEC source: 0001125345-24-000002 · wk-form4_1705960631.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,984 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023. Read SEC document |
| December 20, 2023 Filed Dec 21, 2023 21:12 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 18,880 | $10.08 | $190,310.40 |
DisclosureSEC source: 0001125345-23-000131 · wk-form4_1703193165.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 101,300 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2023 Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:34 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 9,375 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-23-000040 · wf-form4_167727445351772.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:34 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 3,619 | $6.55 | $23,704.45 |
DisclosureSEC source: 0001125345-23-000040 · wf-form4_167727445351772.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,180 Read SEC document |
| February 22, 2023 Filed Feb 24, 2023 21:34 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-23-000040 · wf-form4_167727445351772.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:30 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-23-000035 · wf-form4_167666940392252.xml · derivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F3 · derivative.expiration_date: The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:30 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 200,000 | $0.00 Strike: $4.82 | $0.00 |
DisclosureSEC source: 0001125345-23-000035 · wf-form4_167666940392252.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-02-15 F1 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
| May 14, 2022 Filed May 17, 2022 21:28 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-22-000051 · wf-form4_165282278330600.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which vested on May 14, 2022. Restricted stock units convert into the Company's common stock on a one-for-one basis F1 · derivative.exercise_date: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which vested on May 14, 2022. Restricted stock units convert into the Company's common stock on a one-for-one basis F1 · derivative.expiration_date: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which vested on May 14, 2022. Restricted stock units convert into the Company's common stock on a one-for-one basis Read SEC document |
| May 14, 2022 Filed May 17, 2022 21:28 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 1,666 | $4.16 | $6,930.56 |
DisclosureSEC source: 0001125345-22-000051 · wf-form4_165282278330600.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,424 Read SEC document |
| May 14, 2022 Filed May 17, 2022 21:28 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-22-000051 · wf-form4_165282278330600.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On May 14, 2020, the reporting person was granted 10,000 restricted stock units, 50% of which vested on May 14, 2021 and 50% of which vested on May 14, 2022. Restricted stock units convert into the Company's common stock on a one-for-one basis Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:46 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 37,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-22-000025 · wf-form4_164574996410940.xml · derivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The RSUs will vest as to 25% of the total shares one year after the date of grant and 75% two years after the date of grant. F3 · derivative.expiration_date: The RSUs will vest as to 25% of the total shares one year after the date of grant and 75% two years after the date of grant. Read SEC document |
| February 22, 2022 Filed Feb 25, 2022 00:46 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee stock option (right to buy) · Derivative | 75,000 | $0.00 Strike: $10.15 | $0.00 |
DisclosureSEC source: 0001125345-22-000025 · wf-form4_164574996410940.xml · derivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2032-02-22 F1 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
| November 16, 2021 Filed Nov 16, 2021 22:30 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 2,540 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001125345-21-000117 · wf-form4_163710182184861.xml · derivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,540 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. Read SEC document |
| November 16, 2021 Filed Nov 16, 2021 22:30 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 2,540 | $16.00 | $40,640.00 |
DisclosureSEC source: 0001125345-21-000117 · wf-form4_163710182184861.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 29, 2021 00:14 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 4,221 | $20.53 Strike: $20.53 | $86,657.13 |
DisclosureSEC source: 0001125345-21-000089 · wf-form4_162492566930067.xml · derivative · entry 4 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,279 Underlying: Common Stock · 4,221 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 29, 2021 00:14 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionEmployee stock option (right to buy) · Derivative | 21,855 | $16.00 Strike: $16.00 | $349,680.00 |
DisclosureSEC source: 0001125345-21-000089 · wf-form4_162492566930067.xml · derivative · entry 3 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,540 Underlying: Common Stock · 21,855 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable on the date reflected and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. Read SEC document |
| June 24, 2021 Filed Jun 29, 2021 00:14 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 4,221 | $20.53 | $86,657.13 |
DisclosureSEC source: 0001125345-21-000089 · wf-form4_162492566930067.xml · nonDerivative · entry 2 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 24, 2021 Filed Jun 29, 2021 00:14 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 21,855 | $16.00 | $349,680.00 |
DisclosureSEC source: 0001125345-21-000089 · wf-form4_162492566930067.xml · nonDerivative · entry 1 Bonvini Ezio · CIK 0001588365 · Sr VP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.